Green Tea Catechins Decrease Total and Low-Density Lipoprotein Cholesterol: A Systematic Review and Meta-Analysis


      Green tea catechins (GTCs) have been studied in randomized control trials for their lipid-lowering effects. Studies, however, have been small and demonstrated conflicting results. The objective of this study was to perform a systematic review and meta-analysis of randomized controlled trials evaluating the relationship between GTCs and serum lipid levels, including total, low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol, and triglycerides. A systematic literature search of MEDLINE, EMBASE, Cochrane CENTRAL, and the Natural Medicines Comprehensive Database was conducted through March 2010. Randomized controlled trials evaluating GTCs vs control in human beings and reporting efficacy data on at least one of the aforementioned serum lipid endpoints were included. Weighted mean differences for changes from baseline (with 95% confidence intervals [CIs]) for lipid endpoints were calculated using random-effects models. Twenty trials (N=1,415) met all inclusion criteria. Upon meta-analysis, GTCs at doses ranging from 145 to 3,000 mg/day taken for 3 to 24 weeks reduced total (−5.46 mg/dL [−0.14 mmol/L]; 95% CI −9.59 to −1.32) and LDL cholesterol (−5.30 mg/dL [−0.14 mmol/L]; 95% CI −9.99 to −0.62) compared to control. GTCs did not significantly alter HDL cholesterol (−0.27 mg/dL [−0.007 mmol/L]; 95% CI −1.62 to 1.09) or triglyceride (3.00 mg/dL [−0.034 mmol/L]; 95% CI −2.73 to 8.73) levels. The consumption of GTCs is associated with a statistically significant reduction in total and LDL cholesterol levels; however, there was no significant effect on HDL cholesterol or triglyceride levels.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lloyd-Jones D.
        • Adams R.
        • Carnethon M.
        Heart disease and stroke statistics—2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2009; 119: 480-486
        • National Cholesterol Education Program
        Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
        National Heart, Lung, and Blood Institute, Bethesda, MD2002 (NIH Publication No. 02-5215)
        • McKay D.
        • Blumberg J.
        Roles for epicagallocatechin gallate in cardiovascular disease and obesity: An introduction.
        J Am Coll Nutr. 2007; 26: 362S-365S
        • Ikeda I.
        • Imasato Y.
        • Sasaki E.
        • Nakayama M.
        • Nagao H.
        • Takeo T.
        • Yayabe F.
        • Sugano M.
        Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats.
        Biochem Biophys Acta. 1992; 1127: 141-146
        • Yang T.T.
        • Koo M.W.
        Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion.
        Life Sci. 2000; 66: 411-423
        • Muramatsu K.
        • Fukuyo M.
        • Hara Y.
        Effect of green tea catechism on plasma cholesterol level in cholesterol-fed rats.
        J Nutr Sci Vitaminol. 1986; 32: 613-622
        • Tsubono Y.
        • Tsugane S.
        Green tea intake in relation to serum lipid levels in middle-aged Japanese men and women.
        Ann Epidemiol. 1997; 7: 280-284
        • Tokunaga S.
        • White I.R.
        • Frost C.
        • Tanaka K.
        • Kono S.
        • Tokudome S.
        • Akamatsu T.
        • Moriyama T.
        • Zakouji H.
        Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan.
        Ann Epidemiol. 2002; 12: 157-165
        • Batista G.A.P.
        • da Cunha C.L.P.
        • Scartezini M.
        • von der Heyde R.
        • Bitencourt M.G.
        • de Melo S.F.
        Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.
        Arq Bras Cardiol. 2009; 93: 121-127
        • Brown A.L.
        • Lane J.
        • Coverly J.
        • Stocks J.
        • Jackson S.
        • Stephen A.
        • Bluck L.
        • Coward A.
        • Hendrickx H.
        Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial.
        Br J Nutr. 2009; 101: 886-894
        • Di Pierro F.
        • Menghi A.B.
        • Barreca A.
        • Lucarelli M.
        • Calandrelli A.
        GreenSelect phytosome as an adjunct to a low-calorie diet for treatment of obesity: A clinical trial.
        Alt Med Rev. 2009; 14: 154-160
        • Eichenberger P.
        • Colombani P.C.
        • Mettler S.
        Effects of 3-week consumption of green tea extracts on whole-body metabolism during cycling exercise in endurance-trained men.
        Int J Vitam Nutr Res. 2009; 79: 24-33
        • Frank J.
        • George T.W.
        • Lodge J.K.
        • Rodriguez-Mateos A.M.
        • Spencer J.P.E.
        • Minihane A.M.
        • Rimbach G.
        Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men.
        J Nutr. 2009; 139: 58-62
        • Maki K.C.
        • Reeves M.S.
        • Farmer M.
        • Yasunaga K.
        • Matsuo N.
        • Katsuragi Y.
        • Komikado M.
        • Tokimitsu I.
        • Wilder D.
        • Jones F.
        • Blumberg J.B.
        • Cartwright Y.
        Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults.
        J Nutr. 2009; 139: 264-270
        • Bertipaglia de Santana M.
        • Mandarino M.G.
        • Cardoso J.R.
        • Dichi I.
        • Bandeira Dichi J.
        • Camargo A.E.I.
        • Fabris B.A.
        • Rodrigues R.J.
        • Fatel E.C.S.
        • Nixdorf S.L.
        • Simão A.N.
        • Cecchini R.
        • Barbosa D.S.
        Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects.
        Nutrition. 2008; 24: 562-568
        • Fukino Y.
        • Ikeda A.
        • Maruyama K.
        • Aoki N.
        • Okubo T.
        • Iso H.
        Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.
        Eur J Clin Nutr. 2008; 62: 953-960
        • Hsu C.H.
        • Tsai T.H.
        • Kao Y.H.
        • Hwang K.C.
        • Tseng T.Y.
        • Chou P.
        Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial.
        Clin Nutr. 2008; 27: 363-370
        • Matsuyama T.
        • Tanaka Y.
        • Kamimaki I.
        • Nagao T.
        • Tokimitsu I.
        Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children.
        Obesity. 2008; 16: 1338-1348
        • Nagao T.
        • Megura S.
        • Hase T.
        • Otsuka K.
        • Komikado M.
        • Tokimitsu I.
        • Yamamoto T.
        • Yamamoto K.
        A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes.
        Obesity. 2008; 17: 310-317
        • Takeshita M.
        • Takashima S.
        • Harada U.
        • Shibata E.
        • Hosoya N.
        • Takase H.
        • Otsuka K.
        • Meguro S.
        • Komikado M.
        • Tokimitsu I.
        Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans.
        Jpn Pharmacol Ther. 2008; 36: 767-776
        • Inami S.
        • Takano M.
        • Yamamoto M.
        • Murakami D.
        • Tajika K.
        • Yodogawa K.
        • Yokoyama S.
        • Ohno N.
        • Ohba T.
        • Sano J.
        • Ibuki C.
        • Seino Y.
        • Mizuno K.
        Tea catechin consumption reduces circulating low-density lipoprotein.
        Int Heart J. 2007; 48: 725-732
        • Nagao T.
        • Hase T.
        • Tokimitsu I.
        A green tea extract high in catechins reduces body fast and cardiovascular risks in humans.
        Obesity. 2007; 15: 1473-1483
        • Chan C.C.W.
        • Koo M.W.L.
        • Ng E.H.Y.
        • Tang O.S.
        • Yeung W.S.B.
        • Ho P.C.
        Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—A randomized, placebo-controlled trial.
        J Soc Gynecol Investig. 2006; 13: 63-68
        • Ryu O.H.
        • Lee J.
        • Lee K.W.
        • Kim H.Y.
        • Seo J.A.
        • Kim S.G.
        • Kim N.H.
        • Baik S.H.
        • Choi D.S.
        • Choi K.M.
        Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients.
        Diabet Res Clin Prac. 2006; 71: 356-358
        • Erba D.
        • Riso P.
        • Bordoni A.
        • Foti P.
        • Biagi P.L.
        • Testolin G.
        Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans.
        J Nutr Biochem. 2005; 16: 144-149
        • Maron D.J.
        • Lu G.P.
        • Cai N.S.
        • Wu Z.G.
        • Li Y.H.
        • Chen H.
        • Zhu J.Q.
        • Jin X.J.
        • Wouters B.C.
        • Zhao J.
        Cholesterol-lowering effect of a theaflavin-enriched green tea extract.
        Arch Intern Med. 2003; 163: 1448-1453
        • Princen H.M.G.
        • van Duyvenvoorde W.
        • Buytenhek R.
        • Blonk C.
        • Tijburg L.M.B.
        • Langius J.A.E.
        • Meinders A.E.
        • Pijl H.
        No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers.
        Arterioscler Thromb Vasc Biol. 1998; 18: 833-840
        • Van het Hof K.H.
        • de Boer H.S.M.
        • Wiseman S.A.
        • Lien N.
        • Weststrate J.A.
        • Tijburg L.B.M.
        Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans.
        Am J Clin Nutr. 1997; 66: 1125-1132
        • American Dietetic Association
        Evidence Analysis Manual: Adapted for Dietary Guidelines 2010 Nutrition Evidence Library—USDA.
        American Dietetic Association, Chicago, IL2008
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Follmann D.
        • Elliot P.
        • Suh I.
        • Cutler J.
        Variance imputation for overviews of clinical trials with continuous response.
        J Clin Epidemiol. 1992; 45: 769-773
        • Imai K.
        • Nakachi K.
        Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases.
        BMJ. 1995; 310: 693-696
        • Food and Drug Administration Web site
        Qualified Health Claims: Letter of denial—Green tea and reduced risk of cardiovascular disease.
        (Accessed August 25, 2009)
        • Sarma D.N.
        • Barrett M.L.
        • Chavez M.L.
        • Gardiner P.
        • Ko R.
        • Mahady G.B.
        • Marles R.J.
        • Pellicore L.S.
        • Giancaspro G.I.
        • Low Dog T.
        Safety of green tea extracts: A systematic review by the US Pharmacopeia.
        Drug Saf. 2008; 31: 469-484


      A. Kim is a pharmacy practice resident, University of Connecticut School of Pharmacy, Hartford, CA.


      A. Chiu is a research scientist, University of Connecticut School of Pharmacy, Hartford, CA.


      M. K. Barone is a research scientist, University of Connecticut School of Pharmacy, Hartford, CA.


      F. Wang is an associate clinical professor of pharmacy practice, University of Connecticut School of Pharmacy, Hartford, CA.


      C. I. Coleman is an associate professor of pharmacy practice, University of Connecticut School of Pharmacy, Hartford, CA.


      O. J. Phung is an assistant professor of pharmacy practice, College of Pharmacy, Western University of Health Sciences, Pomona, CA.